Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Soleno Therapeutics (SLNO) has a market cap of $3.22 billion USD. According to our data, Soleno Therapeutics is ranked No.3248 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $3.22 B |
66.22%
|
| Dec 31, 2024 | $1.94 B |
11.68%
|
| Dec 29, 2023 | $1.74 B |
1,932.83%
|
| Dec 30, 2022 | $85.37 M |
-67.80%
|
| Dec 31, 2021 | $0.27 B |
-78.76%
|
| Dec 31, 2020 | $1.25 B |
-34.35%
|
| Dec 31, 2019 | $1.90 B |
71.93%
|
| Dec 31, 2018 | $1.11 B |
-5.00%
|
| Dec 29, 2017 | $1.16 B |
-55.56%
|
| Dec 30, 2016 | $2.62 B |
-56.22%
|
| Dec 31, 2015 | $5.98 B |
23.99%
|
| Dec 31, 2014 | $4.82 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Rhythm Pharmaceuticals
RYTM
|
$3.93 B |
0.000 M
|
USA
|
 Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
Denmark
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
| Market Cap | = | SLNO Stock Price | * | SLNO Shares Outstanding |
| = | $70.25 | * | 45.86 M | |
| = | $3.22 B |